Categories
WHO Products Alert: Potential safety issue affecting women living with HIV using dolutegravir at the time of conception
WHO Statement on DTG – Geneva, 18 May 2018
http://www.who.int/medicines/publications/drugalerts/Statement_on_DTG_18May_2018final.pdf?ua=1
